HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VIGONVITA-B

87.150

+0.7000.81%

Volume:90.80K

Turnover:8.16M

Market Cap:14.64B

PE:-32.05

High:93.400

Open:89.800

Low:85.000

Close:86.450

52wk High:134.900

52wk Low:51.000

Shares:168.00M

HK Float Shares:167.00M

Volume Ratio:1.00

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.719

ROE:-123.98%

ROA:-20.73%

PB:28.12

PE(LYR):-32.05

PS:122.90

Loading ...

Overview Company News Filings

Vigonvita Life Sciences Sets 28 Aug 2026 Board Meeting to Approve H1 Results and Consider Interim Dividend

Bulletin Express

Vigonvita Schedules Board Meeting to Review Interim Results

Vigonvita converts 100.22 million domestic shares into H shares, lifting issued H-share base to 166.90 million

Bulletin Express

Vigonvita Life Sciences Converts 100.22 Million Domestic Shares into H Shares, Increasing Hong Kong-Listed Float by 150%

Bulletin Express

Vigonvita Files Hong Kong Next-day Disclosure Return Reporting 100.22 Million Shares Converted, Boosting Share Capital

VIGONVITA-B Finalizes Full Circulation of H Shares

VIGONVITA-B Receives Stock Exchange Approval for Full H-Share Circulation

Vigonvita Life Sciences Wins Hong Kong Listing Approval for 100,220,667 Converted H Shares Under Full Circulation Plan

Vigonvita Life Sciences Announces Current Board Line-up and Committee Assignments

Bulletin Express

VIGONVITA-B Announces New Board Chairman and Management Appointments

Vigonvita Life Sciences: Shareholders Endorse 2025 Results, Scrap Supervisory Committee and Renew Board at 2026 AGM

Bulletin Express

Vigonvita Life Sciences Files Board and Board Committee Member List for Disclosure Responsibilities

Vigonvita Appoints Tian Guanghui General Manager in Senior Management Reshuffle

Vigonvita Life Sciences Secures CSRC Green Light for 100.22 Million H-Share Full Circulation

Bulletin Express

VIGONVITA-B Receives CSRC Approval for H-Share Full Circulation Plan

Vigonvita Says CSRC Completes Filing for H-share Full Circulation of 100,220,667 Shares

Vigonvita Life Sciences announces postponement of annual general meeting

Vigonvita Life Sciences calls 26 June 2026 AGM; tables board overhaul, RMB50 million subsidiary guarantees and fresh H-share mandates

Bulletin Express

Vigonvita Schedules 26 June 2026 AGM to Decide on Board Overhaul, Supervisory Committee Abolition and Share Issuance Mandates

Bulletin Express

Vigonvita to Replace Deloitte with HLB Hodgson Impey Cheng; Estimated 2026 Audit Fee Set at RMB 2.48 Million

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/02630/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02630\",,,,,undefined,":{"symbol":"02630","market":"HK","secType":"STK","nameCN":"VIGONVITA-B","latestPrice":87.15,"timestamp":1787299687040,"preClose":86.45,"halted":0,"volume":90800,"delay":0,"changeRate":0.008097165991902867,"floatShares":167000000,"shares":168000000,"eps":-2.718847948309796,"marketStatus":"Market Closed","change":0.7,"latestTime":"08-21 16:08:07","open":89.8,"high":93.4,"low":85,"amount":8159170,"amplitude":0.097166,"askPrice":87.15,"askSize":200,"bidPrice":86.55,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-2.7421856989390645,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1762358400000,"exchange":"SEHK","adjPreClose":86.45,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.9951775554496757,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02630\",,,,,undefined,":{"symbol":"02630","floatShares":167000000,"roa":"-20.73%","roe":"-123.98%","lyrEps":-2.718848,"volumeRatio":0.9951775554496757,"shares":168000000,"dividePrice":0,"high":93.4,"amplitude":0.097166,"preClose":86.45,"low":85,"week52Low":51,"pbRate":"28.12","psRate":"122.90","week52High":134.9,"institutionHeld":0,"latestPrice":87.15,"committee":0.5,"eps":-2.718847948309796,"divideRate":0,"volume":90800,"delay":0,"ttmEps":-2.7421856989390645,"open":89.8,"prevYearClose":81.85,"prevWeekClose":91.9,"prevMonthClose":95.15,"prevQuarterClose":63.55,"fiveDayClose":91.9,"twentyDayClose":78,"sixtyDayClose":82.7,"earningDate":1787846400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02630\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-31","symbol":"02630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774920600000,"name":null,"time":"","dateTimestamp":1774886400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02630\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02630\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02630\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02630","date":"2026-08-21","current":-31.781217,"percent":0.098446,"low":-51.703739,"twenty":-30.680976,"median":-23.843893,"eighty":-16.143388,"high":-9.647367,"avg":-24.490606,"sd":8.071886,"marketCap":14606148270},"quantilePoints":[{"date":"2025-11-07","current":-19.090342,"twenty":-21.84559,"median":-19.090342,"eighty":-13.424557,"marketCap":4407358491},{"date":"2025-11-14","current":-19.641187,"twenty":-19.420849,"median":-16.095168,"eighty":-15.264414,"marketCap":4547380470},{"date":"2025-11-21","current":-17.28769,"twenty":-19.452561,"median":-18.09445,"eighty":-15.501254,"marketCap":4000627980},{"date":"2025-11-28","current":-20.095977,"twenty":-19.591091,"median":-19.037434,"eighty":-16.046947,"marketCap":4667399310},{"date":"2025-12-05","current":-22.096294,"twenty":-21.259546,"median":-19.451229,"eighty":-16.716837,"marketCap":5140806954},{"date":"2025-12-12","current":-20.997063,"twenty":-21.601599,"median":-19.578567,"eighty":-17.610394,"marketCap":4894101562},{"date":"2025-12-19","current":-23.416326,"twenty":-21.853997,"median":-20.095977,"eighty":-18.35497,"marketCap":5470858762},{"date":"2025-12-24","current":-23.9553,"twenty":-22.587001,"median":-20.380599,"eighty":-18.745749,"marketCap":5614214598},{"date":"2026-01-02","current":-23.818881,"twenty":-23.195416,"median":-20.975608,"eighty":-18.936771,"marketCap":5604213028},{"date":"2026-01-09","current":-24.028271,"twenty":-23.242124,"median":-21.499422,"eighty":-19.069179,"marketCap":5667556305},{"date":"2026-01-16","current":-25.359291,"twenty":-23.625318,"median":-21.781264,"eighty":-19.370201,"marketCap":6000941970},{"date":"2026-01-23","current":-26.793845,"twenty":-23.828886,"median":-22.096294,"eighty":-19.449016,"marketCap":6334327635},{"date":"2026-01-30","current":-27.921283,"twenty":-24.928673,"median":-22.61666,"eighty":-19.453005,"marketCap":6631040876},{"date":"2026-02-06","current":-29.544924,"twenty":-25.987891,"median":-22.879289,"eighty":-19.503447,"marketCap":7034437531},{"date":"2026-02-13","current":-30.629205,"twenty":-27.286118,"median":-23.1966,"eighty":-19.616139,"marketCap":7334484630},{"date":"2026-02-20","current":-34.884005,"twenty":-27.587073,"median":-23.306067,"eighty":-19.674728,"marketCap":8341309338},{"date":"2026-02-27","current":-31.168111,"twenty":-28.783656,"median":-23.424434,"eighty":-19.866309,"marketCap":7534516029},{"date":"2026-03-06","current":-27.5285,"twenty":-28.691787,"median":-23.667752,"eighty":-20.125096,"marketCap":6601036167},{"date":"2026-03-13","current":-30.889856,"twenty":-29.277344,"median":-23.818881,"eighty":-20.297184,"marketCap":7441168042},{"date":"2026-03-20","current":-35.008205,"twenty":-30.149829,"median":-23.991785,"eighty":-20.606532,"marketCap":8401318758},{"date":"2026-03-27","current":-24.261842,"twenty":-30.04822,"median":-24.440897,"eighty":-20.962736,"marketCap":5807578284},{"date":"2026-04-02","current":-13.839173,"twenty":-29.95186,"median":-24.028271,"eighty":-20.954154,"marketCap":5600879172},{"date":"2026-04-10","current":-14.403566,"twenty":-29.707698,"median":-23.912102,"eighty":-20.183335,"marketCap":5874255417},{"date":"2026-04-17","current":-13.931767,"twenty":-29.472848,"median":-23.687448,"eighty":-19.490947,"marketCap":5684225588},{"date":"2026-04-24","current":-13.154764,"twenty":-29.345649,"median":-23.63573,"eighty":-19.048016,"marketCap":5367509206},{"date":"2026-04-30","current":-11.730061,"twenty":-29.261806,"median":-23.42038,"eighty":-17.610394,"marketCap":4787418149},{"date":"2026-05-08","current":-12.584922,"twenty":-29.118763,"median":-23.285925,"eighty":-15.264414,"marketCap":5154142380},{"date":"2026-05-15","current":-12.982213,"twenty":-28.928188,"median":-23.15168,"eighty":-14.197911,"marketCap":5330836783},{"date":"2026-05-22","current":-13.28049,"twenty":-28.680958,"median":-22.671486,"eighty":-13.975486,"marketCap":5440854052},{"date":"2026-05-29","current":-30.758632,"twenty":-28.951155,"median":-22.671486,"eighty":-13.922465,"marketCap":12645254010},{"date":"2026-06-05","current":-26.663627,"twenty":-28.786309,"median":-23.15168,"eighty":-13.953626,"marketCap":10977655900},{"date":"2026-06-12","current":-24.767111,"twenty":-28.478214,"median":-23.285925,"eighty":-14.04116,"marketCap":10189946240},{"date":"2026-06-18","current":-23.79348,"twenty":-28.413466,"median":-23.416326,"eighty":-14.041546,"marketCap":9812851190},{"date":"2026-06-26","current":-24.094013,"twenty":-28.02179,"median":-23.475951,"eighty":-14.17377,"marketCap":9888270200},{"date":"2026-07-03","current":-23.973985,"twenty":-27.941384,"median":-23.572922,"eighty":-14.1825,"marketCap":9846370750},{"date":"2026-07-10","current":-22.062739,"twenty":-27.729315,"median":-23.424434,"eighty":-14.21114,"marketCap":9050281200},{"date":"2026-07-17","current":-23.043014,"twenty":-27.655709,"median":-23.42038,"eighty":-14.359864,"marketCap":9486035480},{"date":"2026-07-24","current":-31.748257,"twenty":-27.941384,"median":-23.52511,"eighty":-14.401931,"marketCap":13072628400},{"date":"2026-07-31","current":-38.65537,"twenty":-28.640355,"median":-23.612983,"eighty":-14.919422,"marketCap":15946930670},{"date":"2026-08-07","current":-47.358881,"twenty":-29.345649,"median":-23.667752,"eighty":-15.264958,"marketCap":19575423040},{"date":"2026-08-14","current":-37.215568,"twenty":-30.11107,"median":-23.79348,"eighty":-15.618859,"marketCap":15402237820},{"date":"2026-08-21","current":-35.214198,"twenty":-30.680976,"median":-23.843893,"eighty":-16.143388,"marketCap":14606148270}],"updateTime":1787454447059},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02630\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1198012611","title":"Vigonvita Life Sciences Sets 28 Aug 2026 Board Meeting to Approve H1 Results and Consider Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1198012611","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198012611?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:47","pubTimestamp":1787042876,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences has announced that its board of directors will convene on 28 August 2026 to review and approve the Group’s interim results for the six months ended 30 June 2026. The agenda...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660684224","title":"Vigonvita Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660684224","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660684224?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:38","pubTimestamp":1787042307,"startTime":"0","endTime":"0","summary":"Vigonvita schedules board meeting to review interim resultsVigonvita Life Sciences will hold a board meeting on Aug. 28, 2026 to review interim results for the six months ended June 30, 2026.Directors","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL16Wcj6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180874528","title":"Vigonvita converts 100.22 million domestic shares into H shares, lifting issued H-share base to 166.90 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1180874528","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180874528?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:27","pubTimestamp":1785922053,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. filed its Monthly Return for Equity Issuer for the period ended 31 July 2026 with the Hong Kong Stock Exchange, detailing a substantial restructuring of its share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148163359","title":"Vigonvita Life Sciences Converts 100.22 Million Domestic Shares into H Shares, Increasing Hong Kong-Listed Float by 150%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148163359","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148163359?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:05","pubTimestamp":1784109928,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) announced that on 15 July 2026 it completed the conversion of 100.22 million domestic unlisted shares into H shares. The move follows earlier...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651459273","title":"Vigonvita Files Hong Kong Next-day Disclosure Return Reporting 100.22 Million Shares Converted, Boosting Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2651459273","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651459273?lang=en_us&edition=fundamental","pubTime":"2026-07-15 17:47","pubTimestamp":1784108872,"startTime":"0","endTime":"0","summary":"Vigonvita files Hong Kong next-day disclosure return reporting 100.22 million shares converted, boosting share capitalVigonvita filed a next-day disclosure return reporting the conversion of 100,220,6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDLbhJk03:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107562193","title":"VIGONVITA-B Finalizes Full Circulation of H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1107562193","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107562193?lang=en_us&edition=fundamental","pubTime":"2026-07-15 17:38","pubTimestamp":1784108309,"startTime":"0","endTime":"0","summary":"The company has announced the successful conversion of 100,220,667 domestic unlisted shares into H shares, completed on July 15, 2026.These 100,220,667 newly converted H shares are scheduled to...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114390870","title":"VIGONVITA-B Receives Stock Exchange Approval for Full H-Share Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=1114390870","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114390870?lang=en_us&edition=fundamental","pubTime":"2026-07-06 08:12","pubTimestamp":1783296737,"startTime":"0","endTime":"0","summary":"The company has announced that it received approval from the Stock Exchange on July 3, 2026, for the listing and trading of 100,220,667 H-shares.This approval pertains to the total number of domestic unlisted shares that are to be converted and listed.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","IPOS","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649614313","title":"Vigonvita Life Sciences Wins Hong Kong Listing Approval for 100,220,667 Converted H Shares Under Full Circulation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2649614313","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649614313?lang=en_us&edition=fundamental","pubTime":"2026-07-06 08:01","pubTimestamp":1783296070,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences wins Hong Kong listing approval for 100,220,667 converted H shares under full circulation planVigonvita Life Sciences received Hong Kong listing approval on July 3, 2026 for 10","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL9DWbMf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113335976","title":"Vigonvita Life Sciences Announces Current Board Line-up and Committee Assignments","url":"https://stock-news.laohu8.com/highlight/detail?id=1113335976","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113335976?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:24","pubTimestamp":1782829479,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. released an updated roster of its Board of Directors, confirming six members and detailing their roles across three specialised committees. The Board now comprises...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111612887","title":"VIGONVITA-B Announces New Board Chairman and Management Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=1111612887","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111612887?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:08","pubTimestamp":1782828509,"startTime":"0","endTime":"0","summary":"The board of VIGONVITA-B (02630) has announced a series of appointments and re-elections following its annual general meeting.Dr. Guanghui Tian and Dr. Tianwen Hu have been re-elected as executive...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187127246","title":"Vigonvita Life Sciences: Shareholders Endorse 2025 Results, Scrap Supervisory Committee and Renew Board at 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1187127246","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187127246?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:04","pubTimestamp":1782828252,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) received comprehensive shareholder backing at its postponed 2026 annual general meeting (AGM) held on 30 June in Suzhou, cementing a broad corporate...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647554678","title":"Vigonvita Life Sciences Files Board and Board Committee Member List for Disclosure Responsibilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2647554678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647554678?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:04","pubTimestamp":1782828243,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences files board and board committee member list for disclosure responsibilitiesVigonvita named its board lineup, led by executive directors Dr. Tian Guanghui, Dr. Hu Tianwen.Non-ex","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL6yFLwP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647873554","title":"Vigonvita Appoints Tian Guanghui General Manager in Senior Management Reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=2647873554","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647873554?lang=en_us&edition=fundamental","pubTime":"2026-06-30 21:59","pubTimestamp":1782827985,"startTime":"0","endTime":"0","summary":"Vigonvita appoints Tian Guanghui general manager in senior management reshuffleVigonvita named executive director Tian Guanghui as chairman of its second-session board, effective June 30, 2026, for a ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL4nkm9G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0119","BK0188","600256","02630","BK0028","BK0196","BK0019","BK1191","BK0012","BK0274","BK0183","BK0000","BK0029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170174390","title":"Vigonvita Life Sciences Secures CSRC Green Light for 100.22 Million H-Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=1170174390","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170174390?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:05","pubTimestamp":1782727523,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. announced it has received a filing notice from the China Securities Regulatory Commission (CSRC) approving its H-share full-circulation application. The approval...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152157189","title":"VIGONVITA-B Receives CSRC Approval for H-Share Full Circulation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1152157189","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152157189?lang=en_us&edition=fundamental","pubTime":"2026-06-29 17:50","pubTimestamp":1782726619,"startTime":"0","endTime":"0","summary":"The China Securities Regulatory Commission has issued a filing notice to VIGONVITA-B (02630) regarding the implementation of its H-share full circulation plan.According to the notice, the filing...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647676320","title":"Vigonvita Says CSRC Completes Filing for H-share Full Circulation of 100,220,667 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2647676320","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647676320?lang=en_us&edition=fundamental","pubTime":"2026-06-29 17:45","pubTimestamp":1782726343,"startTime":"0","endTime":"0","summary":"Vigonvita says CSRC completes filing for H-share full circulation of 100,220,667 sharesVigonvita received a China securities regulator filing notice for its H-share full circulation plan.The filing co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL9hgLl0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643249729","title":"Vigonvita Life Sciences announces postponement of annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2643249729","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643249729?lang=en_us&edition=fundamental","pubTime":"2026-06-14 19:45","pubTimestamp":1781437556,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences will hold its postponed annual general meeting in Suzhou, China on June 30, 2026.The meeting was rescheduled from June 26 due to internal work-schedule adjustments.Shareholders will vote on the resolutions set out in the June 4 AGM notice and the June 14 supplemental notice.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigonvita Life Sciences Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 14, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260614:nNDL8nM9B5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180313934","title":"Vigonvita Life Sciences calls 26 June 2026 AGM; tables board overhaul, RMB50 million subsidiary guarantees and fresh H-share mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1180313934","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180313934?lang=en_us&edition=fundamental","pubTime":"2026-06-04 23:03","pubTimestamp":1780585420,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences (Vigonvita) has issued a circular convening its 2026 annual general meeting (AGM) for 26 June 2026 in Suzhou. Fifteen resolutions will be put to vote, spanning financial...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116682637","title":"Vigonvita Schedules 26 June 2026 AGM to Decide on Board Overhaul, Supervisory Committee Abolition and Share Issuance Mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1116682637","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116682637?lang=en_us&edition=fundamental","pubTime":"2026-06-04 23:02","pubTimestamp":1780585375,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. will convene its 2026 annual general meeting (AGM) at 10:00 a.m. on 26 June 2026 at the group’s Suzhou headquarters (8th Floor, Building A, No. 108 Yuxin Road,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198311803","title":"Vigonvita to Replace Deloitte with HLB Hodgson Impey Cheng; Estimated 2026 Audit Fee Set at RMB 2.48 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1198311803","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198311803?lang=en_us&edition=fundamental","pubTime":"2026-06-04 22:23","pubTimestamp":1780582990,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. announced that incumbent auditor Deloitte Touche Tohmatsu will retire at the end of the 26 June 2026 annual general meeting after the two parties failed to agree on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":55,"code":"91000000","status":"200"}]}}